characteristics.text: SAMN33244692
characteristics.characteristic: External Id
characteristics.text: Vignali Lab, Immunology, University of Pittsburgh
characteristics.characteristic: INSDC center name
characteristics.text: 2024-08-11T00:00:00Z
characteristics.characteristic: INSDC first public
characteristics.text: 2024-08-11T15:19:34.917Z
characteristics.characteristic: INSDC last update
characteristics.text: SRS16730800
characteristics.characteristic: INSDC secondary accession
characteristics.text: live
characteristics.characteristic: INSDC status
characteristics.text: Generic
characteristics.characteristic: NCBI submission model
characteristics.text: Generic.1.0
characteristics.characteristic: NCBI submission package
characteristics.text: SRS16730800
characteristics.characteristic: SRA accession
characteristics.text: female
characteristics.characteristic: biological sex
characteristics.text: Live CD45+ immune cells
characteristics.characteristic: cell type
characteristics.text: IV
characteristics.characteristic: disease stage
characteristics.text: TCR sequencing
characteristics.characteristic: library type
characteristics.text: Homo sapiens
characteristics.ontologyTerms: http://purl.obolibrary.org/obo/NCBITaxon_9606
characteristics.characteristic: organism
characteristics.text: Blood
characteristics.characteristic: source_name
characteristics.text: Week 4
characteristics.characteristic: timepoint
characteristics.text: Blood
characteristics.characteristic: tissue
characteristics.text: Patient_3_Week4_PBMC_TCR
characteristics.characteristic: title
characteristics.text: nivolumab
characteristics.characteristic: treatment